UPDATE : Monday, September 7, 2020
상단여백
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease by Shim Hyun-tai 2020-08-26 17:47
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients by Shim Hyun-tai 2020-08-26 17:17
HK inno.N, T&R Biofab to develop skin therapy using 3D tech by Shim Hyun-tai 2020-08-26 16:19
Virus cases rebound above 300, pushing nation closer to tightest restrictions by Shim Hyun-tai 2020-08-26 13:35
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status by Shim Hyun-tai 2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate by Shim Hyun-tai 2020-08-25 16:57
Huons' eye drop wins Saudi’s regulatory nod by Shim Hyun-tai 2020-08-25 14:50
New virus cases below 300 for 2nd day but spreads continue by Shim Hyun-tai 2020-08-25 11:51
HK inno.N publishes P3 trial results of drug on gastric ulcers by Shim Hyun-tai 2020-08-24 18:02
Intron Bio secures new drug substance for bacterial pneumonia by Shim Hyun-tai 2020-08-24 18:01
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax by Shim Hyun-tai 2020-08-24 16:12
Genexine begins global P3 trial of anemia drug by Shim Hyun-tai 2020-08-24 16:12
Despite fall in new virus cases, calls rise for tightest social distancing by Shim Hyun-tai 2020-08-24 15:42
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country by Shim Hyun-tai 2020-08-22 19:08
Seoul using near 80% of Covid-19 sickbeds by Shim Hyun-tai 2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments by Shim Hyun-tai 2020-08-21 16:06
Daewoong to co-develop esophagitis drug for treating Covid-19 by Shim Hyun-tai 2020-08-20 18:41
Korea speeds up developing coronavirus-related products by Shim Hyun-tai 2020-08-20 17:58
Three-digit daily viruses for a week, raising fears about 2nd round by Shim Hyun-tai 2020-08-20 14:56
SNUBH team finds gene mutation causing stomach cancer within families by Shim Hyun-tai 2020-08-19 21:10
여백
여백
여백
Back to Top